Imvaria San Francisco
Berkeley, US · Founded 2019 · 3 known investors
IMVARIA develops AI-driven software-as-medical-device solutions that analyze medical imaging and data to provide non-invasive diagnostic assessments for lung diseases, including idiopathic pulmonary fibrosis and interstitial lung disease. The company's FDA-authorized tools serve pulmonologists and other clinicians to reduce the need for invasive biopsy testing.
AI & Machine LearningHealthtechMedical Devices
Founders & leadership
Imvaria San Francisco was founded in 2019 by Joshua Reicher and Michael Muelly.
JR
Joshua ReicherCo-founder & CEO
MM
Michael MuellyCo-founder & CTO
Investors · 3
Competitors · 4
by search overlapIQVIA7 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Alvaria6 shared keywordsAlvaria provides infrastructure and orchestration for proactive, compliant customer outreach, letting enterprises design and execute campaigns across voice, SMS/MMS, and email with built-in governance and compliance controls. It routes customer interactions into agentic-led, human-led, or hybrid experiences and integrates with contact center platforms such as Zoom Contact Center.
Itnonline5 shared keywordsITN (Imaging Technology News) is an online trade publication covering radiology and medical imaging, reporting on news, products, and clinical developments across modalities like CT, ultrasound, and breast imaging. It serves radiology professionals, imaging departments, and healthcare technology providers.
Vida Lung4 shared keywordsVIDA provides AI-powered imaging biomarkers and clinical trial imaging services for life-sciences sponsors, built on its VIDA Intelligence Platform to collect and analyze imaging data across drug development and trials. Its quantitative imaging covers respiratory, cardiovascular, oncology, neurology, musculoskeletal, and gastroenterology therapeutic areas, along with digital biobank capabilities.
Companies competing with Imvaria San Francisco for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Imvaria San Francisco do?
- IMVARIA develops AI-driven software-as-medical-device solutions that analyze medical imaging and data to provide non-invasive diagnostic assessments for lung diseases, including idiopathic pulmonary fibrosis and interstitial lung disease. The company's FDA-authorized tools serve pulmonologists and other clinicians to reduce the need for invasive biopsy testing.
- Who founded Imvaria San Francisco?
- Imvaria San Francisco was founded by Joshua Reicher, Michael Muelly in 2019.
- Who are Imvaria San Francisco's investors?
- Imvaria San Francisco's investors include Creative Ventures, InHealth Ventures, Meridian Street Capital.
- Where is Imvaria San Francisco headquartered?
- Imvaria San Francisco is headquartered in Berkeley, US.